The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Healthcare & Insurance

CV Sciences, Inc. Wins 2019 NEXTY Award

Company’s industry-dominating hemp extract brand, PlusCBD Oil™, wins Consumer Choice Award at Natural Products Expo East SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent

Tuesday, September 17, 2019

Sampo plc: Managers’ Transactions (Alsaker)

SAMPO PLC                           MANAGERS’

Tuesday, September 17, 2019

Sampo plc: Managers’ Transactions (Magnusson)

SAMPO PLC                           MANAGERS’ TRANSACTIONS                    17 September 2019 at 3:35 pm Sampo plc: Managers’ Transactions (Magnusson) Sampo plc (business code 0142213-3) has received the following notification under Article 19 of

Tuesday, September 17, 2019

Sampo plc: Managers’ Transactions (Lapveteläinen)

SAMPO PLC                           MANAGERS’ TRANSACTIONS                    17 September 2019 at 3:35 pm Sampo plc: Managers’ Transactions (Lapveteläinen) Sampo plc (business code 0142213-3) has received the following notification under Article

Tuesday, September 17, 2019

Sampo plc: Managers’ Transactions (Martinsen)

SAMPO PLC                           MANAGERS’ TRANSACTIONS                    17 September 2019 at 3:35 pm Sampo plc: Managers’ Transactions (Martinsen) Sampo plc (business code 0142213-3) has received the following notification under Article 19 of

Tuesday, September 17, 2019

Sampo plc: Managers’ Transactions (Wennerklint)

SAMPO PLC                        MANAGERS’ TRANSACTIONS                    17 September 2019 at 3:30 pm Sampo plc: Managers’ Transactions (Wennerklint) Sampo plc (business code 0142213-3) has received the following notification under Article 19 of the

Tuesday, September 17, 2019

Sampo plc: Managers’ Transactions (Thorsrud)

SAMPO PLC                        MANAGERS’ TRANSACTIONS                    17 September 2019 at 3:30 pm Sampo plc: Managers’ Transactions (Thorsrud) Sampo plc (business code 0142213-3) has received the following notification under Article 19 of the

Tuesday, September 17, 2019

Sampo plc: Managers’ Transactions (Niemisvirta)

SAMPO PLC                        MANAGERS’ TRANSACTIONS                    17 September 2019 at 3:30 pm Sampo plc: Managers’ Transactions (Niemisvirta) Sampo plc (business code 0142213-3) has received the following notification under Article 19 of the

Tuesday, September 17, 2019

Sampo plc: Managers’ Transactions (Stadigh)

SAMPO PLC                        MANAGERS’ TRANSACTIONS                    17 September 2019 at 3:30 pm Sampo plc: Managers’ Transactions (Stadigh) Sampo plc (business code 0142213-3) has received the following notification under Article 19 of the

Tuesday, September 17, 2019

Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™

SOLANA BEACH, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has completed manufacturing commercial scale batches of its product candidate Gimoti

Tuesday, September 17, 2019

Avricore Health and Clinart MENA Announce Interim Agreement for HealthTab™ + RASTR Network Middle East Expansion

VANCOUVER, British Columbia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") is pleased to announce that it has signed a first stage agreement in the form of a Letter of Intent (LOI) with Dubai based clinical research

Tuesday, September 17, 2019

Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding

WESTLAKE VILLAGE, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that it has elected to file a voluntary petition to allow restructuring under Chapter 11 of the Bankruptcy Code. “We believe

Tuesday, September 17, 2019

KemPharm to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases

CELEBRATION, Fla., Sept. 17, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its president and chief executive officer, Travis C. Mickle, Ph.D., will host one-on-one

Tuesday, September 17, 2019

Orphazyme CMO to speak at FDA-funded rare disease data analytics platform launch event

Orphazyme A/SInvestor news                                                                                                            No. 04/2019                                                                 

Tuesday, September 17, 2019

Fujifilm Exercises License Option in GvHD

MELBOURNE, Australia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that FUJIFILM Corporation (“Fujifilm”) has today exercised its license option in graft-versus-host

Tuesday, September 17, 2019

Tyme Technologies to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24, 2019

NEW YORK, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24,

Tuesday, September 17, 2019

Philips launches NightBalance, increasing therapy options for positional obstructive sleep apnea patients

September 17, 2019 Clinically-validated sleep position treatment provides a comfortable, easy-to-use alternative for positional obstructive sleep apnea patientsUpdates include wireless connectivity and new mobile app Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global

Tuesday, September 17, 2019

Immutep Announces Japanese Patent Grant for LAG525 Antibody

SYDNEY, Australia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”) is pleased to announce the grant of patent no. 6576962 entitled “Antibody molecules to LAG-3 and uses thereof” by the Japanese Patent Office. The claims of the

Tuesday, September 17, 2019

Centrexion Therapeutics Announces Completion of Patient Enrollment in VICTORY-3 Phase 3 Open-Label Clinical Trial of CNTX-4975 in Patients with

- CNTX-4975 Phase 3 clinical development program fully enrolled - - VICTORY-1 pivotal and VICTORY-3 open-label topline results expected in Q1 2020; VICTORY-2 pivotal results expected in Q3 2020 - BOSTON, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Centrexion Therapeutics Corporation, a company focused

Tuesday, September 17, 2019

Yale Cancer Center to Present on the Synergistic Relationship Between Intravenously-Administered SB 11285, Spring Bank’s STING Agonist Development

HOPKINTON, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that Dr. Thomas Hayman,

Tuesday, September 17, 2019

loading

© 2019 Stock News Now